SpectraBase Spectrum ID |
2o49YS5zFaa |
Name |
Barverine-A |
Classification |
Pharmaceutical drug artifact |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
315.158291545 u |
Formula |
C17H21N3O3 |
InChI |
InChI=1S/C17H21N3O3/c1-18-14(21)17(13-9-5-3-6-10-13,15(22)19(2)16(18)23)20-11-7-4-8-12-20/h3,5-6,9-10H,4,7-8,11-12H2,1-2H3 |
InChIKey |
YIPXOBXLGCHEBB-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
315.373 g/mol |
Nominal Mass |
315 u |
Quality |
898 |
Retention Index |
2549 |
SMILES |
C1(C(N(C(N(C1=O)C)=O)C)=O)(N1CCCCC1)C1=CC=CC=C1 |
SPLASH |
splash10-0002-9103000000-d7802c51799b12f66d48 |
Sample Comments |
Structure uncertain |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
1,3-dimethyl-5-phenyl-5-(piperidin-1-yl)-1,3-diazinane-2,4,6-trione |
Technique |
GC/MS |
Wiley ID |
DD2024_011838 |